Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04824430 · ClinicalTrials.gov registry record
Assessment of Uterine Access, Uterine Patency and Intrauterine Adhesions Following Endometrial Ablation
A clinical trial of Intrauterine Adhesion, sponsored by Rejoni.
- Completed
- Registry status
- 36
- Enrollment target
- 1
- Study location
NCT04824430 is a study of Intrauterine Adhesion that has completed, run by Rejoni. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04824430, a study of Intrauterine Adhesion, has completed, sponsored by Rejoni.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to gain information concerning the acute and longer-term morphological changes within the uterus following endometrial ablation. Hysteroscopic evaluation of the uterine cavity will be used to determine if physical access and the ability to systematically assess the post-ablation uterine cavity were preserved. The presence, location and severity of intrauterine adhesions will be documented in participants who are 3, 6 and 12 months from their standard of care endometrial ablation.
Conditions Studied
Study Locations (1)
Indiana
- Basinksi and Juran, MD's - Newburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-03-23 |
| Est. Completion | 2021-07-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04824430
The ClinicalTrials.gov registry entry for NCT04824430 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rejoni, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intrauterine Adhesion appearing as the primary indexed condition, and to 0 interventions.
NCT04824430 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT04824430 about?
NCT04824430 is a clinical study titled "Assessment of Uterine Access, Uterine Patency and Intrauterine Adhesions Following Endometrial Ablation". The objective of this study is to gain information concerning the acute and longer-term morphological changes within the uterus following endometrial ablation. Hysteroscopic evaluation of the uterine cavity will be used to determine if physical access and the ability to systematically assess the pos...
What is the current status of trial NCT04824430?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2021-03-23. Estimated completion is 2021-07-22.
What conditions does trial NCT04824430 study?
This clinical trial studies the following conditions: Intrauterine Adhesion.
Who is sponsoring clinical trial NCT04824430?
This trial is sponsored by Rejoni, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04824430 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.